In its latest stroke of ambush journalism, the non-profit Project Veritas (PV) exposes a bureaucratic executive admitting the Biden administration’s long-term COVID vaccine plans, which include annual jabs, even for children as young as six months old.
“Biden wants to inoculate as many people as possible,” said Christopher Cole, executive officer of Countermeasures Initiative for the U.S. Food and Drug Administration (FDA). In hidden camera recordings of conversations with an undercover PV reporter, Cole predicted that mandates for regular COVID jabs are coming. Here is the conversation in footage PV identifies from January 21:
Cole: “So, you’ll have to get an annual shot. I mean, it hasn’t been formally announced yet ‘cause they don’t want to, like, rile everyone up.”
PV: “Is it going to be formally announced?”
Cole: “Yeah, yeah at some point … I mean, it’s going to be, and some of it’s been talked about publicly. But it hasn’t been talked about on like CNN or Fox or MSNBC or anything. But yeah, it’ll — you’ll have to get an annual.”
In another video that PV says was recorded February 3, Cole reconfirmed his prediction: “I think what’s going to happen is it’s going to be a gradual thing. I think school’s going to mandate it.” He even forecasts boosters and yearly jabs for infants.
PV: “Why do they [toddlers] need the third one [COVID vaccine]?”
Cole: “Well, the same reason you or I would need the third one … because … the vaccine … it wanes. Your ability to fight it wanes. So the three will bolster your system and then there will be an annual … just like the flu shot.”
PV: “For the toddlers?”
Cole: “Well, for everyone.”
PV: “Okay. So, the toddlers, too, then will have to get it annually?”
Cole: “Probably. I mean, that’s in the future, we aren’t sure. That might involve more studies.”
Lack of those studies may be what stalled a February 15 FDA Advisory Committee Meeting to discuss authorizing the Pfizer jab for six-month-old infants. PV founder James O’Keefe says in his exposé that the agency wanted to grant approval by the end of the month but postponed the meeting for lack of completed testing. Cole offered chilling revelations in regard to that.
PV: “You guys have been in the news a lot the last couple days.”
Cole: “Yeah, we’re looking at trying to approve – I don’t completely agree with … the [FDA] process. They’re looking at trying to inoculate kids under five years old – between six months and five years old.”
PV: “What do you mean you don’t agree with the process?”
Cole: “Well, I mean, they don’t have all the – all the tests aren’t there. So I agree with the thing that it is important to inoculate them [toddlers], but you can’t provide the parent as much assurity (sic) as you normally want to.”
He further explained how his agency is employing Emergency Use Authorization (EUA) with Covid vaccines to circumvent standard drug approval protocols. EUA is only intended for temporary use during public health emergencies, according to the FDA website.
PV: “Do you think it’s really an emergency for the toddlers?”
Cole: “[T]hey’re all being approved under that standard… The efficacy data doesn’t have to be as high. The standard is on emergency use authorizations is that it does more benefit than harm.”
PV: “So how do you know it’s already getting approved [for toddlers]?”
Cole: “Well, they’re not going to, I mean, just from everything I’ve heard, they’re not going to not approve it.”
PV: “I thought their cases weren’t that high for six months to four-year-olds.”
Cole: “They’re not, but it – because it’s related to Covid, it’s under that approval process.”
When the PV asked him how many infants are involved in the trials, he said he had not looked into that but chillingly admitted, “There’s always a chance of a long, long term effects, especially with someone younger.” He also made a waffling confession about inadequacy of testing in pregnant women.
Cole: “They haven’t tested enough on pregnancy, on vaccines and everything and women ‘cause they have different, you know, systems than men and…”
PV: “They haven’t tested enough?”
Cole: “Well, they have, but they haven’t done enough prior. Now they have also been very good at promoting that, but that was an issue for a period of time.”
PV: “Well, I feel like that’s still an issue…”
Cole: “It is still an issue. It’s still – we still haven’t gotten there… It’s hard to find, like, pregnant women for these studies and a significant number in order to be statistically accurate.”
In other footage Cole conceded the ineffectiveness of the Pfizer vaccine. When the PV reporter mentioned articles that claimed the first two shots do not work well, Cole wavered, “There, there has been … yes, it is – has not been as effective as they’re expecting, I agree.”
After contacting FDA for comment before publishing the hidden camera footage, PV received this dodgy response from the agency’s press officer, Abby Capobianco: “The person purportedly in the video does not work on vaccine matters and does not represent the views of the FDA.” But Cole’s picture and resume on the professional social networking website LinkedIn identify him as FDA Executive Officer of Medical Countermeasures Initiative, and the agency website calls vaccines one of its most important MCMs. Moreover, if he is not the man in the video, PV has certainly unearthed Cole’s doppleganger.
Cole told the PV reporter that he has been with FDA for more than 20 years and is directly involved in the approval process of various Covid vaccines. “My agency oversees vaccines, vaccine approvals and devices for vaccines. And my office clears all the emergency approvals,” he stated. “Since Covid’s under an emergency order, we expedite the approval of any emergency. I’ve been there like twenty-two years.”
O’Keefe announced this video release as part one of a two-part series and played teaser highlights from the sequel, which he says will include information about the “billions of dollars exchanging hands between our government and Big Pharma, and what really goes on behind the scenes during the approval process.”
“The drug companies, the food companies, the vaccine companies, they pay us hundreds of millions of dollars a year to hire and keep the reviewers to approve their products,” Cole revealed. “There’s almost a billion dollars a year going into FDA’s budget from the people we regulate.” He exposed Big Pharma’s money motive: “If they can get every person required at an annual vaccine, that is a recurring return of money going into their company.”
